FDA Approves First in the World Device to Treat Patients with Congenital Heart Disease
According to the Mach 26,2021 news release, the new implant device provides a less invasive option to treat pulmonary valve regurgitation for patients with a native or surgically-repaired right ventricular outflow tract. The approval comes following the release of pivotal trial data that was first reported at the virtual SCAI 2020 meeting. The US FDA has …